ANVISA registration 10339840328Valid until Sep 05, 2036ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV)
ANVISA Registration Number: 10339840328DIASORIN LTDADIASORIN ITALIA S.P.A. UK BRANCHRisk Class IV
Device names
- Technical name
- ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV)
- Risk class
- Class IV
PT: ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
Registration details
- Registration Number
- 10339840328
- Process Number
- 25351219967201112
- CNPJ
- 01896764000170
Company information
- Registration Holder
- DIASORIN LTDA
- Manufacturer
- DIASORIN ITALIA S.P.A. UK BRANCH
- Manufacturing Country
- United Kingdom
PT: REINO UNIDO
Dates and status
- Publication Date
- Sep 05, 2011
- Validity
- 05/09/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10339840328 and manufactured by DIASORIN ITALIA S.P.A. UK BRANCH. The registration is held by DIASORIN LTDA with validity until Sep 05, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.